M
Michael J. Mack
Researcher at Scott & White Hospital
Publications - 634
Citations - 36680
Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.
Papers
More filters
Journal ArticleDOI
Impact of Short-Term Complications on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement.
Suzanne V. Arnold,Yiran Zhang,Suzanne J. Baron,Thomas C. McAndrew,Maria Alu,Susheel Kodali,Samir R. Kapadia,Vinod H. Thourani,D. Craig Miller,Michael J. Mack,Martin B. Leon,David J. Cohen +11 more
TL;DR: The results suggest that despite considerable progress, efforts to further reduce stroke, acute kidney injury, bleeding, and moderate or severe PVL are likely to yield important clinical benefits and remain key targets for device iteration and procedural improvement.
Journal ArticleDOI
The Role of Thoracoscopy in Lung Cancer Management
Rodney J. Landreneau,Michael J. Mack,Robert D. Dowling,James D. Luketich,Robert J. Keenan,Peter F. Ferson,Stephen R. Hazelrigg +6 more
TL;DR: VATS today can be employed in the evaluation of idiopathic malignant pleural effusions, mediastinal adenopathy, indeterminate pulmonary nodules, and compromise resection and lobectomy of peripheral stage I non-small cell lung cancer.
Journal ArticleDOI
Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Success and safety
Sa'ar Minha,Ron Waksman,Lowell P. Satler,Rebecca Torguson,Oluseun Alli,Charanjit S. Rihal,Michael J. Mack,Lars G. Svensson,Jeevanantham Rajeswaran,Eugene H. Blackstone,E. Murat Tuzcu,Vinod H. Thourani,Raj Makkar,John Ehrlinger,Ashley M. Lowry,Rakesh M. Suri,Kevin L. Greason,Martin B. Leon,David R. Holmes,Augusto D. Pichard +19 more
TL;DR: To identify number of cases needed to maximize device success and minimize adverse events after transfemoral transcatheter aortic valve replacement (TF‐TAVR), and determine if adverse events were linked to the technical performance learning curve.
Journal ArticleDOI
Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial
Vinod H. Thourani,Jessica Forcillo,Nirat Beohar,Darshan Doshi,Rupa Parvataneni,Girma Minalu Ayele,Ajay J. Kirtane,Vasilis Babaliaros,Susheel Kodali,Chandan Devireddy,Wilson Y. Szeto,Howard C. Herrmann,Raj Makkar,Gorav Ailawadi,Scott Lim,Hersh S. Maniar,Alan Zajarias,Rakesh M. Suri,E. Murat Tuzcu,Samir R. Kapadia,Lars G. Svensson,Jose F. Condado,Hanna A. Jensen,Michael J. Mack,Martin B. Leon +24 more
TL;DR: Preoperative severe RD is a significant predictor for 1-year mortality in TAVR patients, and careful risk stratification by the heart team is required in patients with severe preprocedural RD.
Journal ArticleDOI
Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.
Hironori Hara,Patrick W. Serruys,Patrick W. Serruys,Kuniaki Takahashi,Hideyuki Kawashima,Masafumi Ono,Chao Gao,Rutao Wang,Friedrich W. Mohr,David R. Holmes,Piroze M. Davierwala,Stuart J. Head,Daniel J F M Thuijs,Milan Milojevic,Arie Pieter Kappetein,Scot Garg,Yoshinobu Onuma,Michael J. Mack,Syntax Extended Survival Investigators +18 more
TL;DR: The PMI rates according to various definitions, their clinically relevant association with all-cause mortality at 10 years, and their impact on composite endpoints at 5 years were investigated in the SYNTAXES (Synergy between PCI with Taxus and Cardiac Surgery Extended Survival) trial.